Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet? | Front Oncol | 2022 | 36686736 | PubTator, text mining | PubMed |
| Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity. | Front Genet | 2022 | 36685972 | PubTator, text mining | PubMed |
| Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. | Front Genet | 2022 | 36685962 | PubTator, text mining | PubMed |
| Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer. | Front Genet | 2022 | 36685879 | PubTator, text mining | PubMed |
| Noncoding RNAs in Vascular Cell Biology and Restenosis. | Biology (Basel) | 2022 | 36671717 | PubTator, text mining | PubMed |
| Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer. | Ann Transl Med | 2022 | 36660659 | PubTator, text mining | PubMed |
| WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review. | Gland Surg | 2022 | 36654949 | PubTator, text mining | PubMed |
| Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review. | Rep Pract Oncol Radiother | 2022 | 36632296 | PubTator, text mining | PubMed |
| Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. | Front Cell Dev Biol | 2022 | 36619866 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma. | Front Immunol | 2022 | 36601121 | PubTator, text mining | PubMed |
| Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers' progression and diagnosis. | Front Oncol | 2022 | 36591473 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications. | Int J Mol Sci | 2022 | 36555400 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. | Mol Cancer | 2022 | 36550571 | PubTator, text mining | PubMed |
| A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. | Front Cell Dev Biol | 2022 | 36544907 | PubTator, text mining | PubMed |
| Starvation-induced long non-coding RNAs are significant for prognosis evaluation of bladder cancer. | Aging (Albany NY) | 2022 | 36541918 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| Recent advances in machine learning methods for predicting LncRNA and disease associations. | Front Cell Infect Microbiol | 2022 | 36530425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=28